Form 4: 2seventy bio Executive Jessica Snow Acquires Shares and Stock Options

Jessica Snow, a Senior Vice President at 2seventy bio, acquired 106,150 shares of common stock and 70,750 stock options on January 6, 2025.

Summary

• Jessica Snow, a Senior Vice President at 2seventy bio, reported acquiring 106,150 shares of common stock and 70,750 stock options on January 6, 2025.
• The common stock was acquired at a price of $0.00, and the stock options have an exercise price of $2.64.
• The restricted stock units vest ratably over four years, with the first installment vesting on January 2, 2026.
• The stock options vest over four years, with 25% vesting on January 2, 2026, and the remainder in 36 equal monthly installments.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which is generally viewed positively as it aligns executive interests with company performance. There is no indication of any negative sentiment.

Positives

• The acquisition of shares and stock options by a senior executive could be seen as a positive sign of confidence in the company's future.

Future Outlook

The vesting schedules for the stock options and restricted stock units indicate a long-term incentive structure for the executive.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when executives acquire or dispose of company securities. It provides transparency into executive compensation and ownership.

Comparison to Industry Standards

• Stock option grants and restricted stock units are common forms of executive compensation in the biotechnology industry, used to align executive interests with shareholder value.
• The vesting schedules are typical for such grants, encouraging long-term commitment from the executive.
• Companies like CRISPR Therapeutics and Beam Therapeutics also use similar equity-based compensation strategies.

Stakeholder Impact

• The acquisition of shares and stock options by a senior executive could be viewed positively by shareholders, indicating confidence in the company's future.

Key Dates

Keywords

2seventy bio, Jessica Snow, stock options, share acquisition, executive compensation, insider trading, vesting